butyrylcarnitine

Butyrylcarnitine is a plasma metabolite that is an indicator of abnormal metabolism due to disease and is used in the diagnosis of heart failure and pancreatic cysts.

2-Methylbutyrylcarnitine (chloride) acts as a gut microbial metabolite that targets integrin α2β1 on platelets, facilitating the activation of cytosolic phospholipase A2 (cPLA2) and enhancing platelet hyperresponsiveness. This compound further augments platelet hyperreactivity and promotes thrombus formation in mice. It is also characterized as a branched-chain acylcarnitine.

2-Methylbutyrylcarnitine is a fatty acid metabolite primarily present in blood and urine, generated via the pyruvate carboxylation pathway. Its elevated levels in plasma of nonalcoholic steatohepatitis (NASH) subjects enable its use in diagnosing metabolic disorders.

Butyryl carnitine-D3 hydrochloride is a deuterated compound of Butyryl carnitine hydrochloride.

Butyryl Carnitine-D3 Hcl (Standard) is a reference standard of Butyryl Carnitine-D3 Hcl intended for quantitative analysis, quality control, and related biochemical research applications. Butyryl carnitine-d3 HCl is a deuterated compound of Butyryl carnitine HCl.